Flutemetamol (18F)

WikiDoc Resources for Flutemetamol (18F)
Articles
Most recent articles on Flutemetamol (18F) Most cited articles on Flutemetamol (18F) Review articles on Flutemetamol (18F) Articles on Flutemetamol (18F) in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Flutemetamol (18F) Images of Flutemetamol (18F) Photos of Flutemetamol (18F) Podcasts & MP3s on Flutemetamol (18F) Videos on Flutemetamol (18F)
Evidence Based Medicine
Cochrane Collaboration on Flutemetamol (18F) Bandolier on Flutemetamol (18F) TRIP on Flutemetamol (18F)
Clinical Trials
Ongoing Trials on Flutemetamol (18F) at Clinical Trials.gov Trial results on Flutemetamol (18F) Clinical Trials on Flutemetamol (18F) at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Flutemetamol (18F) NICE Guidance on Flutemetamol (18F) NHS PRODIGY Guidance FDA on Flutemetamol (18F) CDC on Flutemetamol (18F)
Books
Books on Flutemetamol (18F)
News
Flutemetamol (18F) in the news Be alerted to news on Flutemetamol (18F) News trends on Flutemetamol (18F)
Commentary
Blogs on Flutemetamol (18F)
Definitions
Definitions of Flutemetamol (18F)
Patient Resources / Community
Patient resources on Flutemetamol (18F) Discussion groups on Flutemetamol (18F) Patient Handouts on Flutemetamol (18F) Directions to Hospitals Treating Flutemetamol (18F) Risk calculators and risk factors for Flutemetamol (18F)
Healthcare Provider Resources
Symptoms of Flutemetamol (18F) Causes & Risk Factors for Flutemetamol (18F) Diagnostic studies for Flutemetamol (18F) Treatment of Flutemetamol (18F)
Continuing Medical Education (CME)
CME Programs on Flutemetamol (18F)
International
Flutemetamol (18F) en Espanol Flutemetamol (18F) en Francais
Business
Flutemetamol (18F) in the Marketplace Patents on Flutemetamol (18F)
Experimental / Informatics
List of terms related to Flutemetamol (18F)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Flutemetamol (¹⁸F) (trade name Vizamyl, by GE Healthcare) is a PET scanning radiopharmaceutical containing the radionuclide fluorine-18, used as a diagnostic tool for Alzheimer's disease.

Mechanism of action

After the substance is given intravenously, it accumulates in beta amyloid plaques in the patient's brain, which thus become visible via positron emission tomography (PET).